Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI)
Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI) Basic information
- Product Name:
- Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI)
- Synonyms:
-
- 5,6,7,8-tetrahydroimidazo[1,5-A]pyrazin
- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine(SALTDATA: 2HCl)
- 4H,5H,6H,7H-iMidazo[1,5-a]pyrazine
- IMidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro-
- Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI)
- 5,6,7,8-Tetrahydroimidazolo[1,5-a]piperazine
- 5H,6H,7H,8H-imidazo[1,5-a]pyrazine
- 1,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyrazine
- CAS:
- 297172-19-1
- MF:
- C6H9N3
- MW:
- 123.16
- Product Categories:
-
- AMINETERTIARY
- 1
- Mol File:
- 297172-19-1.mol
Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI) Chemical Properties
- Boiling point:
- 340.0±30.0 °C(Predicted)
- Density
- 1.33±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C(protect from light)
- pka
- 8.26±0.20(Predicted)
- form
- solid
- color
- Cream
- CAS DataBase Reference
- 297172-19-1
Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI) Usage And Synthesis
Uses
5,6,7,8-Tetrahydroimidazo[1,5-A]pyrazine can be used as KRAS G12C inhibitors as antitumor agents.
Synthesis
165894-09-7
297172-19-1
GENERAL STEPS: 7-Benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine (4.89 g, 22.9 mmol) was dissolved in anhydrous ethanol (200 mL) and 10% palladium carbon catalyst (4.88 g) was added. The reaction mixture was placed under 1 bar hydrogen atmosphere and the reaction was vigorously stirred at room temperature overnight. Upon completion of the reaction, the catalyst was removed by filtration through a diatomaceous earth pad and the filter cake was washed with ethanol. The filtrates were combined, concentrated under reduced pressure and subsequently co-evaporated with dichloromethane to completely remove the residual solvent to afford the target compound 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine as an off-white oil (2.52 g). The product was characterized by 1H NMR (CD3OD): δ 7.42 (s, 1H), 6.77 (s, 1H), 4.07 (s, 2H), 3.99 (t, J = 5.6 Hz, 2H), 3.22 (t, J = 5.6 Hz, 2H), 1.76 (br s, 1H). LC/MS analysis showed m/z 124 [M + H]+, which is consistent with target molecular weight.
References
[1] Patent: WO2015/91795, 2015, A1. Location in patent: Paragraph 36
Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI)Supplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 001-857-928-2050 or 1-888-588-9418
- sales@chemreagents.com
- Tel
- 021-20958197 20965099
- sales@skychemical.com
- Tel
- Please Send Email 18652950785
- chemweiao@163.com
- Tel
- 021-61551611 13296011611
- contact@trustwe.com
Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI)(297172-19-1)Related Product Information
- Azithromycin
- CEFTRIAXONE
- Sulfachoropyrazine sodium
- Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI)
- 7-(6-Chloro-pyrimidin-4-yl)-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine
- 5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE DIHYDROCHLORIDE
- 7-(2-chloropyrimidin-4-yl)-3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
- 7-(2-chloropyrimidin-4-yl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
- Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro-3-methyl- (9CI)
- 7-(6-Chloro-pyrimidin-4-yl)-3-methyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine
- 3-Bromo-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine
- 3-(2,4-DIFLUOROPHENYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,5-A]PYRAZINE
- ETHYL 5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRAZINE-2-CARBOXYLATE